News

ROSWELL, Ga., May 05, 2026 (GLOBE NEWSWIRE) -- Cellution Biologics Inc., a regenerative medicine company focused on advancing human-tissue based products, today announced the expansion of its U.S. headquarters in Roswell, Georgia. The company will commemorate...

ROSWELL, Ga., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellution Biologics Inc., today announced the introduction of AmnioPlast 1™ (Dehydrated Monolayered Human Amnion Membrane Allograft) and AmnioPlast Double™ (Dehydrated, Dual-Layer Amnion Membrane Allograft)...

ROSWELL, Ga., April 07, 2026 (GLOBE NEWSWIRE) -- Cellution Biologics Inc. today announced its official entry into the ocular market at the upcoming American Society of Cataract and Refractive Surgery Annual Meeting, taking place April 10-13 in Washington...

ROSWELL, Ga., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Cellution Biologics Inc. (“Cellution Biologics” or the “Company”), a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, today announced the completion...

Acquisition marks Cellution Biologics' entry into the U.S. reconstructive surgery market through an established human acellular dermal matrix platform. SimpliDerm® expands Cellution Biologics' advanced biologics portfolio beyond wound care, ocular repair...